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Abstract  
Synthesis of the tripeptide Z-Phe-Arg-SerNH2 has been accomplished by a recombinant 
cysteine protease, cathepsin L1 from liver fluke (Fasciola hepatica), using Z-Phe-Arg-OMe 
as acyl acceptor and SerNH2 as nucleophile in 0.1 M ammonium acetate pH 9.0-12.5% v/v 
acetonitrile at 37oC.  LC-MS detection indicated tripeptide formation after 10 min, continuing 
up to 5.5 h. The ester Z-Phe-Arg-OMe was detected throughout the experiment but the 
hydrolysis product Z-Phe-Arg-OH appeared early and in quite large amounts. We believe that 
this is the first application of a parasite protease in enzymatic peptide synthesis. 
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Abbreviations: LC-MS, liquid chromatography-mass spectrometry; m/z, mass-to-charge 
ratio; rFheCL1, recombinant Fasciola hepatica cathepsin L1; Z, benzoyloxycarbonyl. 
 
Introduction 
The helminth parasite Fasciola hepatica (liver fluke) causes disease in cattle and sheep and 
has recently emerged as an important pathogen of humans. The parasite secretes a protease, 
cathepsin L1 (EC 3.4.22.15), which plays an important role in many aspects of its 
pathogenicity (e.g. nutrient acquisition) by cleaving host proteins to absorbable peptides. 
Cathepsin L1 also cleaves matrix proteins such as fibronectin and collagen, thereby aiding 
parasite migration through host tissue (e.g. liver and intestine) and has been implicated in the 
inactivation of host immune defences by cleavage of immunoglobulins  [1-4].  
Cathepsin L1 is a lysosomal cysteine proteinase belonging to the papain superfamily.  It has 
only endopeptidase activity and preferentially cleaves peptide bonds with hydrophobic amino 
acid residues in positions P2 and P3 [5].  The S1′ and S2 binding sites are largely responsible 
for the enzyme’s specificity, with the S2 site being the major determinant. This subsite is a 
deep hydrophobic pocket, which accommodates large hydrophobic residues at the P2 position 
[6,7]. Cathepsin L1 favours substrates with small amino acid side chains (Ala, Ser) or long 
but non-branched (Asn, Gln, Lys) at the P1′ position [8].   
In recent years, proteases have been widely used to form peptide bonds.  Enzymatic peptide 
synthesis offers an alternative to chemical methods, with numerous advantages: reactions 
take place under mild conditions and with high regiospecificity, side chain protection is 
unnecessary and no racemization occurs [9].  Compared with serine proteases, however, there 
have been few reports of the use of cysteine proteases in enzymatic peptide synthesis.  
Recombinant cathepsin L1 (rFheCL1) has been successfully expressed at high level in yeast 
systems, while cathepsin L1 extracted from liver flukes is notably stable [2].  We considered 
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that this stable, conveniently available recombinant cysteine protease might be an interesting 
candidate for peptide synthesis.  Here we report the synthesis of the tripeptide Z-Phe-Arg-
Ser-NH2 by rFheCL1 under kinetic control.  We believe this to be the first time that a 
recombinant parasite protease has been used in this way.  
 
Materials & Methods 
Materials - The synthetic peptide ester Z-Phe-Arg-OMe⋅HCl and nucleophile H-SerNH2.HCl 
were obtained from Bachem (Bubendorf, Switzerland) and were used as supplied. 
Diaminoethanetetra-acetic acid (EDTA), formic acid and sodium acetate anhydrous were 
from Fisher Scientific.  Acetonitrile and water (both CHROMASOLV® grade) were obtained 
from Riedel-de-Haen GmbH while DL-dithothreitol (DL-DTT) was from Sigma.  Prof J.P. 
Dalton’s Parasitology Research Group (Institute for the Biotechnology of Infectious 
Diseases, University of Technology, Sydney, Australia) generously supplied purified 
recombinant Fasciola hepatica Cathepsin L1 (rFheCL1; 0.5mg protein/ml) as a gift.  
Activation of rFheCL1 – The enzyme was activated as required to 0.05mg rFheCL1/ml in a 
mixture comprising rFheCL1 (0.5mg/ml; 0.05ml), DTT (100mM; 0.04ml) and EDTA 
(500mM; 0.01ml) made up to total volume of 0.5ml with 0.1M sodium acetate, pH 5.0. The 
mixture was incubated at 37°C for 2 hr, then stored at -20°C until use. 
Enzymatic Peptide Synthesis - Enzymatic synthesis of Z-Phe-Arg-SerNH2 using Z-Phe-Arg-
OMe HCl (ester) and Ser-NH2 HCl (amine) was performed based on methods described by 
Stehle et al. [10] and Lozano et al. [11].  rFheCL1 was activated to a final concentration of 
0.05mg/ml. Z-Phe-Arg-OMe was prepared as a 20mM stock solution in 100% (w/v) 
acetonitrile while the nucleophile, Ser-NH2, was prepared to 50mM final concentration in 
0.1M ammonium acetate, pH 9.0. Enzyme, nucleophile and ester were pre-incubated 
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separately in a waterbath at 37°C for 15 min prior to assay to ensure thermal equilibrium.  In 
a 5ml volume test tube, 0.25ml Z-Phe-Arg-OMe and 0.4ml Ser-NH2 were combined and the 
volume was adjusted to 2ml with 0.1M ammonium acetate, pH 9.0.  Reaction was initiated by 
the addition of 0.25ml rFheCL1 (0.05mg/ml final conentration) and incubated at 37°C with 
stirring. Aliquots (0.2ml) were removed at intervals and mixed with 0.025ml 
acetonitrile:water:formic acid (50:25:25 v/v/v) to quench the reaction. Analysis was 
performed by liquid chromatography-mass spectrometry (LC-MS) on a Bruker Mass 
Spectrometer with electrospray ionisation and ion-trap detector linked to a Hewlett-Packard 
Esquire Liquid chromatograph 1100 with photodiode array detector.  The LC isocratic 
method used a Zorbax SB-C18, 50 x 2.1 mm, 3.5µm narrow bore column with mobile phase 
25:75:0.1 (v/v/v) acetonitrile:water:formic acid, flow rate 0.2ml/min.  Monitoring was via a 
photodiode array detector at 200nm, injection volume 2µl. 
 
Results 
Concentrations of enzyme, ester and nucleophile rFheCL1-catalyzed synthesis of Z-Phe-Arg-
Ser-NH2 was performed as described above.  Initially, enzyme, ester and nucleophile 
concentrations were 0.5mg/ml, 25mM and 50mM respectively, with an ester:nucleophile 
ratio of 1:2.  Although formation of the desired tripeptide product was detected by mass 
spectrometry, it was not visible on the LC chromatographs, as a peak due to the ester was 
masking the tripeptide peak.  Therefore, concentrations were reduced to 0.05mg/ml rFheCL1, 
2.5mM Z-Phe-Arg-OMe and 10mM SerNH2, giving a 1:4 ester:nucleophile ratio. 
Tripeptide formation As shown in Figure 1, the tripeptide was formed within ten min of 
reaction commencement. The 10 min and 5.5 h traces clearly show two new peaks, eluting at 
3.0 min (m/z 542.3 corresponding to the synthesised tripeptide Z-Phe-Arg-Ser-NH2) and 3.4 
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min (m/z 455.2 ascribed to Z-Phe-Arg-NH2).  The major peak eluting at 4.1 min in all traces 
(m/z 456.2) is due to the hydrolysis product Z-Phe-Arg-OH.    
 
Discussion 
There are two strategies for enzymatic peptide synthesis: kinetically controlled and 
equilibrium controlled synthesis [9,12]. The kinetic method, using ester substrates, was 
preferred due to its lower enzyme requirements and shorter reaction times.  
Specificity of the enzyme for amino acids at the P1′ position is an important and deciding 
factor when considering suitable nucleophiles for use in peptide synthesis. Literature 
indicates that cathepsin L has a preference for small amino acid side chains (Ala, Ser) or for 
long but non-branched (Asn, Gln, Lys) side chains at the P1′ position.  It also indicates the 
order of preference among these residues at this site i.e. Ser > Ala > Lys > Asn > Gln  [8].  
Hence, serine amide was chosen as nucleophile for this synthesis. 
The LC-MS traces in Figure 1 clearly show formation of a new peak eluting at 3 min (m/z 
542.3), corresponding to the molecular weight of the desired tripeptide Z-Phe-Arg-Ser-NH2. 
The new tripeptide could be detected in samples taken at 10 min and up to 5.5 h. We believe 
that the peak eluting at 3.4 min (m/z 455.2) represents Z-Phe-Arg-NH2 formed by cleavage of 
the Ser Nα-Cα bond in the tripeptide product under the acid conditions used for reaction 
quenching and for liquid chromatography. The large peak at 4.1 min had a m/z value of 
456.2, consistent with Z-Phe-Arg-OH. This may have arisen on storage of the ester substrate 
or during sample treatment. We performed peptide synthesis at pH 9.0 in order to maximize 
the concentration of the unionized –NH2 form of the serine amide nucleophile. Use of more 
neutral pH values nearer for the synthetic reaction may reduce the incidence of non-
enzymatic ester hydrolysis.  
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The mass spectrometric data obtained in this work confirmed for us the molecular weights of 
the separated reaction components detected by liquid chromatography. The extra breakdown 
product of the synthesised tripeptide with the m/z value of 455.2 was not expected and hence 
tandem mass spectrometry was not carried out during these experiments. However, further 
work on this project would include fragmentation MS experiments so as to elucidate 
structures of both predicted and unpredicted compounds. Neither the rate nor the total amount 
of product synthesised have been established in the present study. Nevertheless, the results 
obtained prove that rFheCL1 is capable of peptide synthesis. We have yet to ascertain the 
effects of reaction medium, pH and temperature, or of varying the concentrations of enzyme, 
substrate and nucleophile, on the synthetic reaction.   
Synthesis in organic solvents prevents substrate ester hydrolysis as well as unwanted 
proteolysis [12].  Careful selection of the organic solvent for enzyme-catalysed peptide bond 
synthesis is essential, however, as the solvent affects not only the enzyme stability, but also 
solubility of the substrate and yield of peptide product [13]. Stability studies on rFheCL1 [14] 
demonstrated maximum activity in 50% (v/v) acetonitrile. The ester substrate is also soluble 
in this solvent; hence, this would be a good starting point for further investigation of 
rFheCL1-catalyzed peptide synthesis in organic solvents.   
Investigation of the optimum pH for maximum synthetic activity would be instructive, as pH 
can influence kinetically controlled synthesis in two ways (one, binding of the ester substrate 
to the enzyme, leading to esterase activity and, two, deacylation of the acyl-enzyme by the 
nucleophile, leading to synthesis [11]).  
Optimization of the reaction temperature would also be worthwhile. Kinetically controlled 
peptide synthesis has been performed at many temperatures ranging from frozen aqueous 
systems up to 40°C.  Haensler et al. [15] demonstrated that α-chymotrypsin and papain were 
capable of kinetically controlled synthesis using unprotected amino acids as acyl acceptors in 
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a frozen aqueous system, with yields ranging from 43-95% depending on the acyl acceptor.  
Freezing is thought to increase the concentration of reactants in the unfrozen liquid phase that 
is in equilibrium with the ice crystals.  Decreasing the temperature also reduces the extent of 
hydrolytic side reactions that take place at higher temperatures.   
The concentrations of reactants greatly influence the rate of product formation. Decreasing 
the concentration of the reactants enhanced the resolution of the LC chromatographs; this 
could be further optimized.  It would be interesting to establish the highest ester:nucleophile 
ratio that would still allow product formation and to determine the saturation level where 
maximum tripeptide formation is achieved. Here, peptide synthesis was obtained at a 1:4 
ratio. Lozano et al. [11] used papain to catalyse the synthesis of a tripeptide using an 
ester:nucleophile ratio of 1:6.  Elucidation of which nucleophile and acyl acceptor give the 
highest rate of tripeptide formation would also be interesting.  Results could be compared 
with those of Ménard et al. [8], who concluded that cathepsin L favoured serine (amongst 
other amino acids) at the P1′ position.  
The overall usefulness of rFheCL1 as a peptide ligase could be assessed in comparison with, 
e.g., papain and trypsin in model synthesis reactions under identical conditions. Both of these 
well-characterized proteinases have been used previously for peptide synthesis and share with 
rFheCL1 a preference for Arg residues in the P1 position. Both papain and rFheCL1 are 
cysteine proteinases, affording further instructive comparisons.  
 
Conclusion 
Successful synthesis of the tripeptide Z-Phe-Arg-SerNH2 has been achieved with 
recombinant rFheCL1, although the reaction needs further optimization. Review of the 
literature did not reveal any reports of peptide synthesis by parasite proteases to date, so the 
present findings appear to be novel. 
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Legend to Figure 
Figure 1. LC-MS traces of cathepsin L1-catalysed synthesis of Z-Phe-Arg-SerNH2.  
LC traces of samples taken at times zero, 10 min and 5.5 h are indicated on the main figure. 
The 10 min and 5.5 h traces clearly show two new peaks, eluting at 3.0 min (m/z 542.3, 
corresponding to the synthesised tripeptide Z-Phe-Arg-Ser-NH2) and 3.4 min (m/z 455.2, 
ascribed to Z-Phe-Arg-NH2).  The major peak eluting at 4.1 min in all traces (m/z 456.2) is 
due to the hydrolysis product Z-Phe-Arg-OH. The late-eluting diffuse peak on all three traces 
has m/z value of 470, consistent with the Z-Phe-Arg-O-Me acyl acceptor. For full details, see 
materials and methods. 
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